UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

Annals of oncology, 2016-06, Vol.27 (6), p.1041-1047

2016

Volltextzugriff (PDF)

2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S492-S493

2015

Volltextzugriff (PDF)

PCR251 A Conceptual Disease Model for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer (aGC/GEJC): Results From a Targeted Literature Review and Patient Interviews

Value in health, 2024-06, Vol.27 (6), p.S343-S343

2024

Volltextzugriff (PDF)

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

Annals of oncology, 2022-09, Vol.33, p.S1124

2022

Volltextzugriff (PDF)

75TiP Open-label, phase II study of tusamitamab ravtansine (SAR408701) in combination with pembrolizumab and with pembrolizumab + platinum-based chemotherapy +/− pemetrexed in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05)

Annals of oncology, 2022-04, Vol.33, p.S65-S66

2022

Volltextzugriff (PDF)

13MO Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase II study)

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S46-S47

2023

Volltextzugriff (PDF)

1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy

Annals of oncology, 2021-09, Vol.32, p.S1034-S1035

2021

Volltextzugriff (PDF)

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S5-S5-04

2016

Volltextzugriff (PDF)

792PTREATMENT PATTERNS IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (DOC)-BASED CHEMOTHERAPY (CTX): PROXIMA

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv274-iv275

2014

Volltextzugriff (PDF)

Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

Annals of oncology, 2014-09, Vol.25, p.iv274

2014

Volltextzugriff (PDF)

Résultat final de l'essai de chimio-immunothérapie par cisplatine-IL2-IFNα chez 91 patients atteints de mélanome malin métastatique

Pathologie et biologie, 1994, Vol.42 (10), p.1080-1081

1994

Volltextzugriff (PDF)

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Blood cancer journal (New York), 2021-05, Vol.11 (5), p.89-5, Article 89

2021

Volltextzugriff (PDF)

Evaluation of the Electronic Port Right of Way Payment Information System

Management systems in production engineering, 2023-09, Vol.31 (3), p.254-262

2023

Volltextzugriff (PDF)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Haematologica (Roma), 2021-04, Vol.106 (4), p.1182-1187

2021

Volltextzugriff (PDF)

Aissa MERAH et Vincent MEYER (dir.) (2015), La communication publique et territoriale au Maghreb. Enjeux d’une valorisation et défis pour les acteurs: Paris, L’Harmattan

Communication, 2016-08 (vol. 34/1)

Bensfia, Abdellatif

2016

Volltextzugriff (PDF)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Haematologica (Roma), 2022-03, Vol.107 (3), p.774-775

2022

Volltextzugriff (PDF)

Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Elderly Patients with Relapsed/Refractory Multiple Myeloma: Icaria-MM Subgroup Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.1893-1893

2019

Volltextzugriff (PDF)

Guy LOCHARD (2006), L’information télévisée, mutations professionnelles et enjeux citoyens: Paris, Éditions Vuibert

Communication, 2012-01 (Vol. 29/2)

Bensfia, Abdellatif

2012

Volltextzugriff (PDF)

Philippe GABIN et Jean François DORTIER (dir.) (2008), La communication. État des savoirs, troisième édition actualisée: Paris, Éditions Sciences humaines

Communication, 2011-01 (Vol. 28/2)

Bensfia, Abdellatif

2011

Volltextzugriff (PDF)

Validity of the TAM Model in the context of electronic payment ofport dues in Morocco

2022 14th International Colloquium of Logistics and Supply Chain Management (LOGISTIQUA), 2022, p.1-5

2022

Volltextzugriff (PDF)

Digitalization of port passage procedures: focus on the transit time of Goods

2020 IEEE 13th International Colloquium of Logistics and Supply Chain Management (LOGISTIQUA), 2020, p.1-6

2020

Volltextzugriff (PDF)

François HEINDERYCKX (2003), La malinformation. Plaidoyer pour une refondation de l’information: Bruxelles, Éditions Labor, Coll. « Quartier libre

Communication, 2005-02 (Vol. 23/2), p.259-265

Bensfia, Abdellatif

2005

Volltextzugriff (PDF)

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15112-e15112

2012

Volltextzugriff (PDF)

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.172-172

2012

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(25)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(7)
Aged
(5)
Humans
(5)
Life Sciences & Biomedicine
(5)
Hematology
(3)
Middle Aged
(3)
Multiple Myeloma - Drug Therapy
(3)
Oncology
(3)
Antibodies, Monoclonal, Humanized
(2)
Disease-Free Survival
(2)
Electronic Payment
(2)
Engineering
(2)
Engineering, Industrial
(2)
Female
(2)
Information And Communication Technology
(2)
Male
(2)
Supply Chain Management
(2)
Supply Chains
(2)
Taxoids - Administration & Dosage
(2)
Taxoids - Adverse Effects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

PCR251 A Conceptual Disease Model for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer (aGC/GEJC): Results From a Targeted Literature Review and Patient Interviews

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

75TiP Open-label, phase II study of tusamitamab ravtansine (SAR408701) in combination with pembrolizumab and with pembrolizumab + platinum-based chemotherapy +/− pemetrexed in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05)

13MO Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase II study)

1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

792PTREATMENT PATTERNS IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (DOC)-BASED CHEMOTHERAPY (CTX): PROXIMA

Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

Résultat final de l'essai de chimio-immunothérapie par cisplatine-IL2-IFNα chez 91 patients atteints de mélanome malin métastatique

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Evaluation of the Electronic Port Right of Way Payment Information System

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Aissa MERAH et Vincent MEYER (dir.) (2015), La communication publique et territoriale au Maghreb. Enjeux d’une valorisation et défis pour les acteurs: Paris, L’Harmattan

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Elderly Patients with Relapsed/Refractory Multiple Myeloma: Icaria-MM Subgroup Analysis

Guy LOCHARD (2006), L’information télévisée, mutations professionnelles et enjeux citoyens: Paris, Éditions Vuibert

Philippe GABIN et Jean François DORTIER (dir.) (2008), La communication. État des savoirs, troisième édition actualisée: Paris, Éditions Sciences humaines

Validity of the TAM Model in the context of electronic payment ofport dues in Morocco

Digitalization of port passage procedures: focus on the transit time of Goods

François HEINDERYCKX (2003), La malinformation. Plaidoyer pour une refondation de l’information: Bruxelles, Éditions Labor, Coll. « Quartier libre

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

Suchergebnisse filtern